Equities analysts expect Sharps Compliance Corp. (NASDAQ:SMED) to post earnings of ($0.01) per share for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Sharps Compliance’s earnings, with the highest EPS estimate coming in at ($0.01) and the lowest estimate coming in at ($0.02). Sharps Compliance reported earnings per share of ($0.05) during the same quarter last year, which suggests a positive year over year growth rate of 80%. The business is expected to report its next earnings results before the market opens on Wednesday, April 24th.
On average, analysts expect that Sharps Compliance will report full-year earnings of $0.06 per share for the current fiscal year, with EPS estimates ranging from $0.04 to $0.07. For the next year, analysts forecast that the business will post earnings of $0.18 per share, with EPS estimates ranging from $0.08 to $0.35. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that cover Sharps Compliance.
Sharps Compliance (NASDAQ:SMED) last released its earnings results on Wednesday, January 23rd. The industrial products company reported $0.05 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.02. Sharps Compliance had a negative return on equity of 0.21% and a negative net margin of 0.13%. The firm had revenue of $12.39 million during the quarter, compared to analysts’ expectations of $11.40 million. During the same period in the previous year, the firm posted $0.01 EPS.
Shares of NASDAQ:SMED remained flat at $$3.59 during trading on Tuesday. The company had a trading volume of 248 shares, compared to its average volume of 8,598. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.02 and a current ratio of 2.63. Sharps Compliance has a fifty-two week low of $2.97 and a fifty-two week high of $4.77. The firm has a market capitalization of $57.94 million, a PE ratio of -89.75, a price-to-earnings-growth ratio of 3.40 and a beta of 0.16.
A hedge fund recently raised its stake in Sharps Compliance stock. Wells Fargo & Company MN boosted its position in Sharps Compliance Corp. (NASDAQ:SMED) by 16.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 321,500 shares of the industrial products company’s stock after purchasing an additional 44,400 shares during the period. Wells Fargo & Company MN owned approximately 2.00% of Sharps Compliance worth $1,109,000 as of its most recent SEC filing. 20.55% of the stock is owned by institutional investors.
About Sharps Compliance
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Recommended Story: Diversification
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.